Increasing Hispanic and Latino involvement in Alzheimer's disease trials
Improving Hispanic/Latino participation in preclinical Alzheimers disease Trials
This study is looking to find out how to make it easier for Hispanic and Latino people to join clinical trials for Alzheimer's disease, so that the results can better reflect everyone in the U.S. by understanding what stops them from participating and finding ways to help.
Quick facts
| Grant type | Career grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of California-Irvine NIH-funded |
| Lab location | 1 site (Irvine, United States) |
| Project ID | NIH-10885956 on NIH RePORTER |
What this research studies
This research aims to improve the participation of Hispanic and Latino individuals in clinical trials for Alzheimer's disease and related dementias. It focuses on understanding the barriers that prevent these communities from enrolling in preclinical trials, which often require specific biomarker testing and the involvement of a study partner. By identifying modifiable behavioral factors that influence willingness to participate, the research seeks to develop targeted interventions to enhance recruitment efforts. The ultimate goal is to ensure that clinical trial results are representative of the diverse U.S. population.
Who could benefit from this research
Good fit: Ideal candidates for this research are Hispanic and Latino individuals aged 21 and older who are interested in participating in Alzheimer's disease clinical trials.
Not a fit: Patients who are not of Hispanic or Latino descent may not directly benefit from this specific research initiative.
Why it matters
Potential benefit: If successful, this research could lead to more inclusive clinical trials, resulting in safer and more effective treatments for Alzheimer's disease that are applicable to a broader range of patients.
How similar studies have performed: Previous research has shown that targeted recruitment strategies can improve minority participation in clinical trials, suggesting that this approach may be effective.
Where this research is happening
Irvine, United States
- University of California-Irvine — Irvine, United States (Active)
Researchers
- Principal investigator: Salazar, Christian R — University of California-Irvine
- Study coordinator: Salazar, Christian R
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.